BML Investment Partners, L.P. 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-27 2:19 pm Unchanged |
2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS |
BML Investment Partners, L.P. | 218,919 5.200% |
0 (Unchanged) |
Filing |
| 2023-04-27 10:55 am Purchase |
2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS |
BML Investment Partners, L.P. | 218,919 5.200% |
218,919 (New Position) |
Filing |